Steward Partners Investment Advisory’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$838K Sell
21,830
-760
-3% -$29.2K 0.01% 1061
2025
Q1
$875K Sell
22,590
-4,983
-18% -$193K 0.01% 973
2024
Q4
$933K Sell
27,573
-73,316
-73% -$2.48M 0.01% 896
2024
Q3
$4.12M Buy
100,889
+6,502
+7% +$266K 0.04% 419
2024
Q2
$3.63M Buy
94,387
+1,710
+2% +$65.8K 0.04% 414
2024
Q1
$3.97M Buy
92,677
+77,984
+531% +$3.34M 0.04% 388
2023
Q4
$545K Sell
14,693
-1,228
-8% -$45.5K 0.01% 959
2023
Q3
$577K Sell
15,921
-1,328
-8% -$48.1K 0.01% 875
2023
Q2
$615K Sell
17,249
-2,620
-13% -$93.4K 0.01% 865
2023
Q1
$707K Sell
19,869
-745
-4% -$26.5K 0.01% 793
2022
Q4
$724K Sell
20,614
-1,744
-8% -$61.3K 0.01% 772
2022
Q3
$658K Sell
22,358
-168
-0.7% -$4.94K 0.01% 766
2022
Q2
$1.23M Sell
22,526
-582
-3% -$31.7K 0.02% 571
2022
Q1
$1.26M Buy
23,108
+414
+2% +$22.5K 0.02% 622
2021
Q4
$1.25M Sell
22,694
-2,122
-9% -$117K 0.02% 626
2021
Q3
$1.19M Sell
24,816
-237
-0.9% -$11.3K 0.02% 609
2021
Q2
$1.25M Sell
25,053
-5,585
-18% -$278K 0.02% 592
2021
Q1
$1.37M Buy
30,638
+9,157
+43% +$409K 0.02% 539
2020
Q4
$988K Sell
21,481
-8,981
-29% -$413K 0.02% 558
2020
Q3
$1.43M Buy
30,462
+21,468
+239% +$1.01M 0.04% 388
2020
Q2
$459K Sell
8,994
-536
-6% -$27.4K 0.01% 653
2020
Q1
$451K Sell
9,530
-1,334
-12% -$63.1K 0.02% 579
2019
Q4
$638K Buy
10,864
+14
+0.1% +$822 0.02% 568
2019
Q3
$578K Buy
10,850
+722
+7% +$38.5K 0.02% 546
2019
Q2
$506K Sell
10,128
-50,126
-83% -$2.5M 0.02% 557
2019
Q1
$3.15M Sell
60,254
-4,791
-7% -$250K 0.13% 161
2018
Q4
$3.11M Sell
65,045
-2,265
-3% -$108K 0.15% 155
2018
Q3
$3.38M Sell
67,310
-296
-0.4% -$14.9K 0.16% 141
2018
Q2
$3.41M Buy
67,606
+3,058
+5% +$154K 0.2% 115
2018
Q1
$3.15M Buy
64,548
+10,631
+20% +$519K 0.22% 108
2017
Q4
$2.39M Buy
53,917
+47,448
+733% +$2.1M 0.18% 131
2017
Q3
$328K Sell
6,469
-1,969
-23% -$99.8K 0.03% 362
2017
Q2
$454K Buy
8,438
+35
+0.4% +$1.88K 0.05% 287
2017
Q1
$442K Buy
8,403
+5,253
+167% +$276K 0.07% 208
2016
Q4
$151K Buy
+3,150
New +$151K 0.07% 209